Completed PHASE4 INTERVENTIONAL 2-arm NCT00919243

Prednisone for Heart Failure Patients With Hyperuricemia

Prednisone Versus Allopurinol for Symptomatic Heart Failure Patients With Hyperuricemia

Sponsor: Hebei Medical University

Updated 5 times since 2017 Last updated: Aug 31, 2010 Started: Feb 28, 2009 Primary completion: Jul 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart Failure and Hyperuricemia, this trial is completed. The trial is conducted by Hebei Medical University and has accumulated 5 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebei Medical University

Data source: Hebei Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China